Or they could save a lot of money and time by using a special little green plant that purportedly performs miracles ... so I hear.
For the first time in decades, Canadian researchers are probing the potential of a psychedelic drug – ecstasy – for use in psychotherapy in a clinical trial approved by Health Canada.
The Multidisciplinary Association for Psychedelic Studies (MAPS), is investigating the use of MDMA, the pure form of the party drug ecstasy, to assist therapy sessions for people with treatment-resistant post-traumatic stress disorder (PTSD).
Currently available PTSD treatments have little effect on a certain subset of PTSD sufferers considered to be treatment resistant. Dr. Ingrid Pacey, a psychiatrist and the principal investigator for MAPS in Vancouver, says MDMA can help overcome one of the major hurdles for conventional PTSD treatments.
MAPS’ researchers emphasize that in their work MDMA is being used as a tool to aid therapy – not simply as a medication. In each six- to eight- hour session, a study subject is supervised by two trained therapists. The sessions take place in a comfortable room and combine silent reflection, often aided by music, with loose discussions of issues that arise for the subject under the influence of the drug. The therapists are there to guide the subjects through discussions of topics often too challenging to have without the aid of the drug. Cont.
Story from - Global News
Image from - Irene2005 - Flickr
cc 2.0
No comments:
Post a Comment